23andMe Holding Co. (ME)
USD 0.61
(0.0%)
USD 0.61
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 12.46 Million USD | 21.65% |
| 2022 | 10.24 Million USD | -5.02% |
| 2021 | 10.78 Million USD | 72.93% |
| 2020 | 6.23 Million USD | -55.82% |
| 2019 | 14.12 Million USD | 3.22% |
| 2018 | 13.68 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 14.74 Million USD | 18.31% |
| 2023 Q2 | 14.97 Million USD | 26.78% |
| 2023 Q1 | 11.81 Million USD | 15.3% |
| 2023 FY | 12.46 Million USD | 21.65% |
| 2023 Q3 | 15.66 Million USD | 4.59% |
| 2023 Q4 | 12.46 Million USD | -20.43% |
| 2022 Q1 | 11.46 Million USD | 6.23% |
| 2022 Q3 | 11.96 Million USD | -13.37% |
| 2022 Q4 | 10.24 Million USD | -14.32% |
| 2022 FY | 10.24 Million USD | -5.02% |
| 2022 Q2 | 13.8 Million USD | 20.46% |
| 2021 Q1 | 15.27 Million USD | 144.78% |
| 2021 FY | 10.78 Million USD | 72.93% |
| 2021 Q4 | 10.78 Million USD | -37.02% |
| 2021 Q3 | 17.13 Million USD | -3.38% |
| 2021 Q2 | 17.73 Million USD | 16.11% |
| 2020 Q4 | 6.23 Million USD | -61.6% |
| 2020 Q2 | - USD | 0.0% |
| 2020 FY | 6.23 Million USD | -55.82% |
| 2020 Q3 | 16.24 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 14.12 Million USD | 3.22% |
| 2018 FY | 13.68 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aspira Women's Health Inc. | 227 Thousand USD | -5391.189% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -67336.702% |
| Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -1503.139% |
| Standard BioTools Inc. | 20.53 Million USD | 39.293% |
| Inotiv, Inc. | 56.1 Million USD | 77.782% |
| Prenetics Global Limited | 3.12 Million USD | -298.653% |
| Neuronetics, Inc. | 8.09 Million USD | -54.022% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -264.474% |
| Castle Biosciences, Inc. | 7.94 Million USD | -56.95% |
| Psychemedics Corporation | 1.00 USD | -1246499900.0% |
| RadNet, Inc. | 1.00 USD | -1246499900.0% |
| Exact Sciences Corporation | 127.47 Million USD | 90.222% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 96.722% |
| iSpecimen Inc. | - USD | -Infinity% |
| OpGen, Inc. | 1.00 USD | -1246499900.0% |
| Exagen Inc. | 2.87 Million USD | -334.169% |
| Bionano Genomics, Inc. | 22.89 Million USD | 45.551% |
| CareDx, Inc | 19.47 Million USD | 35.982% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 32.06 Million USD | 61.123% |
| Guardant Health, Inc. | 61.94 Million USD | 79.878% |
| Biodesix, Inc. | 1.4 Million USD | -790.357% |
| BioNexus Gene Lab Corp. | 1.13 Million USD | -995.564% |
| Precipio, Inc. | 384 Thousand USD | -3146.094% |
| Natera, Inc. | 40.75 Million USD | 69.418% |
| Fulgent Genetics, Inc. | 5.82 Million USD | -113.918% |
| Sera Prognostics, Inc. | - USD | -Infinity% |
| OPKO Health, Inc. | 65.69 Million USD | 81.027% |
| Personalis, Inc. | 5.66 Million USD | -120.191% |
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Applied DNA Sciences, Inc. | 330.02 Thousand USD | -3676.964% |
| T2 Biosystems, Inc. | 4.81 Million USD | -158.664% |
| Neogen Corporation | 189.26 Million USD | 93.414% |
| Myriad Genetics, Inc. | 20.1 Million USD | 37.985% |
| ICON Public Limited Company | 1.00 USD | -1246499900.0% |
| NeoGenomics, Inc. | 24.15 Million USD | 48.398% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -264.474% |
| MDxHealth SA | 2.77 Million USD | -348.543% |
| Prenetics Global Limited | 3.12 Million USD | -298.653% |
| Illumina, Inc. | 587 Million USD | 97.876% |
| DarioHealth Corp. | 5.06 Million USD | -146.247% |
| ENDRA Life Sciences Inc. | 2.62 Million USD | -375.244% |
| Medpace Holdings, Inc. | 1.00 USD | -1246499900.0% |
| Mainz Biomed B.V. | 613.63 Thousand USD | -1931.328% |
| Trinity Biotech plc | 19.93 Million USD | 37.466% |
| Sotera Health Company | 51.98 Million USD | 76.022% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -67336.702% |